← FDA Drug Approvals (Drugs@FDA)
SIPONIMOD
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2025-01-10
Drug application
- FDA Application #
ANDA218228- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SIPONIMOD
- Generic name
- Siponimod
- Active ingredients
- SIPONIMOD
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- CIPLA LTD
- First approval
- 2025-01-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown